Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
New to the market this month from Ronnie Colemans Signature Series brand is L-Carntine XS 4000, and you guessed right, it has 4,000mg or 4g of carnitine for metabolism and weight management

CPT2 on the inner membrane cleaves the complex, releasing the fatty acid inside the mitochondrial matrix where beta-oxidation occurs Without sufficient L-Carnitine, this shuttle is rate-limiting fatty acids accumulate in the cytoplasm rather than entering the mitochondria for oxidation Providing supraphysiological L-Carnitine ensures the CPT shuttle is never rate-limiting maximising the rate at which fatty acids can be transported into mitochondria and oxidised for energy This is particularly relevant during fasted states and aerobic exercise when fatty acid oxidation is the primary energy source L-Carnitine availability becomes the critical bottleneck L-Carnitine and Androgen Receptor Upregulation The AAS-Specific Benefit This is one of the most clinically interesting and least-known aspects of L-Carnitine in an AAS context: A series of studies by Kraemer et al

Some reported or potential side effects include nausea, facial flushing, decreased appetite, headache, fatigue or drowsiness, yawning/stretching, injection-site irritation, and changes in arousal or spontaneous erections
[6] Like pralmorelin and GHRP-6, ipamorelin does not affect prolactin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), or thyroid-stimulating hormone (TSH) levels